When Science Outpaces Payers: Reimbursement in Molecular Diagnostics
Everolimus in Elderly Hormone-Receptor-Positive Advanced Breast Cancer Patients
LETTER TO THE EDITOR.
The Role of Bioinformatics in Oncology Drug Development-and Precision Medicine
Choosing a BRCA Genetic Testing Laboratory: A Patient-Centric and Ethical Call to Action for Clinicians and Payers
Commentary
Mutations That Drive Lung Cancer Also Driving Frontiers of Treatment
NCCN Guidelines Updates
More Enthusiasm for Newer Melanoma Therapies
Denlinger Discusses Posttreatment Surveillance for Cancer Survivors
Promising News in Treating Multiple Myeloma
Sorting Through Screening Protocols for Colorectal Cancer
NCCN guidelines Updates
Roche Molecular Diagnostic's cobas HPV Test Approved by the FDA
Protecting Bone Health During Cancer Care
New NCCN Prostate Cancer Screening Guidelines Aim for Middle Ground
The Big Data Revolution: From Drug Development to Better Health Outcomes?
Understanding Which Therapy Comes First in Treating Castration-Resistant Prostate Cancer
CVS Caremark Quits for Good: Our Decision to Stop Selling Tobacco Products
NCCN Panel Asks What ACA Means to Cancer Care Delivery
Stem Cells Create a Therapeutic Niche
Cheap and Easy-To-Use Diagnostic Tests to Detect Disease Biomarkers, Including Cancer
The Double Whammy of the Obesity Epidemic: Increased Susceptibility to Cancer
Fast Track for Prima Biomed's CVac Clinical Trial Development Program
